Benitec Biopharma Ltd. | Income Statement
Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
276.80
307.00
247.00
333.00
378.00
Cost of Goods Sold (COGS) incl. D&A
-
3,562.00
6,712.00
5,504.00
5,739.00
Gross Income
-
3,255.00
6,465.00
5,171.00
5,361.00
SG&A Expense
8,743.00
10,848.00
18,715.00
11,006.00
10,522.00
EBIT
8,479.00
14,103.00
25,180.00
16,177.00
15,883.00
Unusual Expense
-
1,071.00
2,991.00
-
41.00
Non Operating Income/Expense
664.40
573.00
3,176.00
273.00
43.00
Pretax Income
7,493.50
13,827.00
24,778.00
16,197.00
15,639.00
Income Tax
454.40
2,318.00
-
10,507.00
3,999.00
Consolidated Net Income
7,039.10
11,509.00
24,778.00
5,690.00
11,640.00
Net Income
7,039.10
11,509.00
24,778.00
5,690.00
11,640.00
Net Income After Extraordinaries
7,039.10
11,509.00
24,778.00
5,690.00
11,640.00
Net Income Available to Common
7,039.10
11,509.00
24,778.00
5,690.00
11,640.00
EPS (Basic)
0.08
0.10
0.17
0.03
0.06
Basic Shares Outstanding
91,301.70
116,618.00
143,680.90
177,120.80
210,454.80
EPS (Diluted)
0.08
0.10
0.17
0.03
0.06
Diluted Shares Outstanding
91,301.70
116,618.00
143,680.90
177,120.80
210,454.80
EBITDA
8,466.20
14,006.00
24,890.00
15,960.00
15,689.00
Non-Operating Interest Income
321.10
774.00
217.00
253.00
242.00
About Benitec Biopharma
View Profile
